This pipeline uses various statistical tests to identify mRNAs whose expression levels correlated to selected clinical features.
Testing the association between 18092 genes and 3 clinical features across 141 samples, statistically thresholded by Q value < 0.05, 3 clinical features related to at least one genes.
-
4 genes correlated to 'Time to Death'.
-
DNAJB9|4189 , ZNF25|219749 , PRKAR2B|5577 , EID1|23741
-
1 gene correlated to 'AGE'.
-
ACOX2|8309
-
17 genes correlated to 'GENDER'.
-
ZFY|7544 , XIST|7503 , PRKY|5616 , RPS4Y1|6192 , CYORF15B|84663 , ...
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=4 | shorter survival | N=0 | longer survival | N=4 |
AGE | Spearman correlation test | N=1 | older | N=0 | younger | N=1 |
GENDER | t test | N=17 | male | N=12 | female | N=5 |
Time to Death | Duration (Months) | 0.2-346 (median=47.5) |
censored | N = 70 | |
death | N = 68 | |
Significant markers | N = 4 | |
associated with shorter survival | 0 | |
associated with longer survival | 4 |
HazardRatio | Wald_P | Q | C_index | |
---|---|---|---|---|
DNAJB9|4189 | 0.51 | 8.695e-07 | 0.016 | 0.329 |
ZNF25|219749 | 0.61 | 1.176e-06 | 0.021 | 0.344 |
PRKAR2B|5577 | 0.69 | 1.571e-06 | 0.028 | 0.336 |
EID1|23741 | 0.5 | 2.398e-06 | 0.043 | 0.336 |
AGE | Mean (SD) | 56.06 (16) |
Significant markers | N = 1 | |
pos. correlated | 0 | |
neg. correlated | 1 |
SpearmanCorr | corrP | Q | |
---|---|---|---|
ACOX2|8309 | -0.4468 | 3.514e-08 | 0.000636 |
GENDER | Labels | N |
FEMALE | 50 | |
MALE | 91 | |
Significant markers | N = 17 | |
Higher in MALE | 12 | |
Higher in FEMALE | 5 |
T(pos if higher in 'MALE') | ttestP | Q | AUC | |
---|---|---|---|---|
ZFY|7544 | 29.49 | 3.831e-57 | 6.93e-53 | 0.998 |
XIST|7503 | -20.36 | 9.187e-41 | 1.66e-36 | 0.9781 |
PRKY|5616 | 23.89 | 1.447e-40 | 2.62e-36 | 0.9987 |
RPS4Y1|6192 | 27 | 1.446e-36 | 2.61e-32 | 1 |
CYORF15B|84663 | 30.53 | 4.471e-34 | 8.08e-30 | 1 |
DDX3Y|8653 | 28.33 | 1.248e-30 | 2.26e-26 | 1 |
KDM5D|8284 | 27.15 | 5.568e-25 | 1.01e-20 | 1 |
TSIX|9383 | -13.94 | 4.454e-24 | 8.05e-20 | 0.9754 |
EIF1AY|9086 | 25.39 | 1.164e-19 | 2.1e-15 | 1 |
TTTY15|64595 | 21.69 | 3.336e-19 | 6.03e-15 | 0.9976 |
-
Expresson data file = SKCM-TM.uncv2.mRNAseq_RSEM_normalized_log2.txt
-
Clinical data file = SKCM-TM.clin.merged.picked.txt
-
Number of patients = 141
-
Number of genes = 18092
-
Number of clinical features = 3
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.